Filter Results:
(150)
Show Results For
- All HBS Web
(237)
- People (2)
- News (71)
- Research (150)
- Multimedia (1)
- Faculty Publications (57)
Show Results For
- All HBS Web
(237)
- People (2)
- News (71)
- Research (150)
- Multimedia (1)
- Faculty Publications (57)
Sort by
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
new drugs and therapies that can be tailored to individuals and result in fewer side effects. Advances in treatments of cancer and infectious diseases are likely to be early benefits of work in genomics, Lechleiter said. Another potential... View Details
Keywords: by Sean Silverthorne
- 24 Mar 2020
- Research & Ideas
These Coronavirus Heroes Show Us How Crisis Leadership Works
Schinecker, CEO of Roche Diagnostics, leads a company that received the FDA’s first emergency use authorization for a commercially developed COVID-19 test on March 13. Roche now believes it can ship up to 400,000 View Details
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
5th Annual Africa Business Conference at Harvard Business School on March 8. Much of the debate over AIDS in Africa has surrounded the high cost of the drugs that have turned the deadly disease into one that patients in the West can now... View Details
Keywords: by Julie Jette
- 08 Dec 2003
- Research & Ideas
Why Europe Lags in Pharmaceuticals and Biotech
the preferred testing ground for Phase 1 clinical trials of new drugs, the benefits of massive R&D spending and economic throw-offs are being enjoyed elsewhere, primarily in the United States and in an increasingly competitive Asia.... View Details
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
in the diabetic space, became MannKind’s marketing partner and helped launch Afrezza in February, 2015. Although the drug had a black box warning and required doctors to perform a lung test on patients,... View Details
Keywords: Sean Silverthorne
- 27 Mar 2012
- First Look
First Look: March 27
Prima facie, it is unclear whether media outlets are favoring their own authors because these are the authors that their readers prefer or simply because they are trying to collude. We provide a test to distinguish between these two... View Details
Keywords: Carmen Nobel
- 30 Mar 2010
- First Look
First Look: March 30
Daniel Kahneman, 217-247. New York: Oxford University Press, 2010. Abstract We test for whether, once "basic needs" are satisfied, there is happiness adaptation to further gains in income using three data sets. Individual German... View Details
Keywords: Sean Silverthorne
- 10 Sep 2008
- Research & Ideas
Long-Tail Economics? Give Me Blockbusters!
by focusing on bigger films that require a bigger commitment." Jeff Robinov believes in blockbusters and his strategy is to create more of them. The pharmaceutical and entertainment industries are similar. R&D costs in both are high. Results are unpredictable.... View Details
- 26 Jun 2000
- Research & Ideas
What’s an Internet Business Model? Ask a Health Care Professional
process of testing drugs and bringing them to market. No matter how ingenious a business model may appear, however, all panelists agreed that the trust of patients remains paramount. Patient trust, then,... View Details
- 30 Jun 2003
- Research & Ideas
Computer Security is For Managers, Too
each warrants. A bank, for instance, might assign the greatest amount of protection to the database that stores its customers' financial information. For a pharmaceutical company, it might be the research servers that hold data on promising View Details
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
I find robust evidence of a negative (positive) relation between unexplained (explained) pay disparity and future firm performance. Additional tests show that the negative relation between unexplained disparity and firm performance is... View Details
Keywords: Sean Silverthorne
- 31 May 2016
- First Look
May 31, 2016
have a higher probability of walking by the clinic for reasons other than vaccination. Method: We obtained data from an employer with a free workplace influenza vaccination clinic. Using each employee’s building entry/exit swipe card data, we View Details
Keywords: Sean Silverthorne
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
Based on the fact that stores prioritize carrying products for which local demand is high, we test the hypothesis that introducing the STS functionality increased the retailer’s overall sales dispersion. We find that, on average, the... View Details
Keywords: Sean Silverthorne
- 14 Jul 2006
- Op-Ed
The Case for Consumer-Driven Medicaid
diabetic and asthmatic enrollees due to increased testing and drug utilization, while management consulting firm McKinsey found that consumer-driven enrollees were more likely to "very carefully follow... View Details
Keywords: by Regina E. Herzlinger
- 15 Jan 2018
- Research & Ideas
A Better Business Model for Fighting Cancer
benefits of sharing data, which can then be used to more quickly identify the most pressing targets and design trials to address them. Innovations to the typical clinical trial model are also being used. In an adaptive platform trial, for example, different View Details
- 18 Nov 2014
- First Look
First Look: November 18
innovative drug candidates for testing in patients. Project teams consisted of Pfizer scientists and academics working side-by-side to reduce the time needed to bring a therapeutic View Details
Keywords: Sean Silverthorne
- 02 Sep 2008
- First Look
First Look: September 3, 2008
Working PapersHiring Cheerleaders: Board Appointments of 'Independent' Directors Authors:Lauren Cohen, Andrea Frazzini, Christopher Malloy Abstract We test the hypothesis that firms appoint independent directors who are overly... View Details
Keywords: Sean Silverthorne
- 23 Mar 2010
- First Look
First Look: March 23
Publications "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance Author: Arthur A. Daemmrich Publication: Chap. 13 in The Fragmentation of U.S. Health Care, Oxford University Press, 2010 Abstract Adverse View Details
Keywords: Martha Lagace
- 07 Aug 2006
- Research & Ideas
Whatever Happened to Caveat Emptor?
basic material needs to concerns about the safety and quality of these products. When products did fail—as happened dramatically in the late 1950s with the antinausea drug Thalidomide—such cases became the focus of aggressive consumer... View Details
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
unconventional field settings. Their mission was to produce a DNA sequencing test that was cost effective, robust, and operable in extreme field conditions. After several months of effort, the team in consultation with company experts... View Details
Keywords: by Martha Lagace